Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lin, Chiao Wen ^a,b   Hsieh, Yih Shou ^a,b   Hsin, Chung Han ^a,b   Su, Chun Wen ^a   Lin, Chien Huang ^c   Wei, Lin Hung ^d   Yang, Shun Fa ^a,b   Chien, Ming Hsien ^c,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THYMINE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NFKB1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DISTANT METASTASIS; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NFKB1 GENE; NFKBIA GENE; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; AGED; ARECA; ASIAN; DISEASE PREDISPOSITION; DRINKING BEHAVIOR; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROMOTER REGION; SMOKING; TAIWAN;

NICOTIANA TABACUM; PIPER BETEL;

ADULT; AGED; ALCOHOL DRINKING; ARECA; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; I-KAPPA B PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SMOKING; TAIWAN;

EID: 84859584568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035078     Document Type: Article

References (42)

1. Chung TT, Pan MS, Kuo CL, Wong RH, Lin CW, et al. (2011) Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan. Carcinogenesis 32: 1063-8.
2. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, et al. (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-92.
3. Biolchini F, Pollastri G, Figurelli S, Chiarini L, (2005) Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatol 54: 405-14.
4. Nagaraj NS, Beckers S, Mensah JK, Waigel S, Vigneswaran N, et al. (2006) Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett 165: 182-94.
5. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, et al. (2008) Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37: 271-7.
6. Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, et al. (2007) The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33: 504-7.
7. Shastry BS, (2002) SNP alleles in human disease and evolution. J Hum Genet 47: 561-6.
8. Karin M, Greten FR, (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-59.
9. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-6.
10. Gilmore TD, (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241-65.
11. Whiteside ST, Israel A, (1997) I kappa B proteins: structure, function and regulation. Semin Cancer Biol 8: 75-82.
12. Bharti AC, Aggarwal BB, (2002) Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 64: 883-8.
13. Nakanishi C, Toi M, (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5: 297-309.
14. Dolcet X, Llobet D, Pallares J, Matias-Guiu X, (2005) NF-kB in development and progression of human cancer. Virchows Arch 446: 475-82.
15. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC, (2006) Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer 119: 2840-50.
16. Jordan RC, Catzavelos GC, Barrett AW, Speight PM, (1996) Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol 32B: 394-400.
17. Chang ET, Birmann BM, Kasperzyk JL, Conti DV, Kraft P, et al. (2009) Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 18: 976-86.
18. Spink CF, Gray LC, Davies FE, Morgan GJ, Bidwell JL, (2007) Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma. Cancer Lett 246: 92-9.
19. Bu H, Rosdahl I, Sun XF, Zhang H, (2007) Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol 133: 859-66.
20. Curran JE, Weinstein SR, Griffiths LR, (2002) Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 188: 103-7.
21. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, et al. (2007) Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol 42: 345-50.
22. Lo SS, Chen JH, Wu CW, Lui WY, (2009) Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 145: 280-5.
23. Zhang P, Wei Q, Li X, Wang K, Zeng H, et al. (2009) A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet 191: 73-7.
24. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, et al. (2006) Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243: 47-54.
25. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (2010) AJCC cancer staging manual (7th ed) New York, NY Springer pp. 111-122.
26. Yang J, Pan WH, Clawson GA, Richmond A, (2007) Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Cancer Res 67: 3127-34.
27. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 2004;6: 203-8.
28. Pacifico F, Leonardi A, (2006) NF-kappaB in solid tumors. Biochem Pharmacol 2006;72: 1142-52.
29. Sun XF, Zhang H, (2007) NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22: 1387-98.
30. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45.
31. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, et al. (2010) Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 21: 506-11.
32. He Y, Zhang H, Yin J, Xie J, Tan X, et al. (2009) IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis 30: 1916-22.
33. Lai KC, Lee TC, (2006) Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts. Mutat Res 599: 66-75.
34. Lin MH, Wang CJ, Huang HP, Chou MY, Chou FP, (2004) The tumorigenic characteristics of lime-piper betel quid-transformed JB6 cells. Arch Toxicol 78: 167-73.
35. Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, et al. (2008) Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 37: 18-25.
36. Huang SF, Chen IH, Liao CT, Wang HM, Liou SH, et al. (2009) Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing. Oral Oncol 45: 16-22.
37. Lin SC, Lu SY, Lee SY, Lin CY, Chen CH, et al. (2005) Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 116: 526-35.
38. Nakao S, Ogata Y, Sugiya H, (2009) Nicotine stimulates the expression of cyclooxygenase-2 mRNA via NFkappaB activation in human gingival fibroblasts. Arch Oral Biol 54: 251-7.
39. Wu HJ, Chi CW, Liu TY, (2005) Effects of pH on nicotine-induced DNA damage and oxidative stress. J Toxicol Environ Health A 68: 1511-23.
40. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, et al. (2002) The function of multiple IkappaB: NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21: 6510-9.
41. Jetten AM, (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7: e003.
42. Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, et al. (2003) Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 4: 450-4.